Navigation Links
Pioneering Researchers Recognized for Scientific Achievements in Gene and Cell Therapy
Date:5/10/2013

Milwaukee, WI (PRWEB) May 10, 2013

The American Society of Gene & Cell Therapy (ASGCT) is honored to recognize Dr. Sonia Skarlatos, PhD, and Dr. Catherine McKeon, PhD as the recipients of the Distinguished Service Award at the Society’s 16th Annual Meeting. This award recognizes an ASGCT member or group that has consistently fostered and enhanced the field of genetic and cellular therapy. The award presentation will begin on Friday, May 17th, at 8:00am in Ballroom E-J at the Salt Palace Convention Center.

Dr. Skarlatos, the Deputy Director of the Division of Cardiovascular Sciences with National Heart, Lung, and Blood Institute is credited for her development in various educational programming designed to support gene and cell therapy investigators as well as ensuring certified good manufacturing practices (GMP) grade vectors are available to researchers. Dr. Skarlatos was also instrumental in the conception and implementation of gene therapy programming within the NHLBI.

Dr. McKeon serves as the Senior Advisor for Genetic Research at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Dr. McKeon organized one of the first Requests for Application of research centered on gene transfer and gene therapy. Her participation in gene therapy symposia during the 1990’s would help to form ASGCT. Dr. McKeon has also been significantly involved in educational speaking events focused on assisting young investigators in obtaining funding to continue their research.

"Both Sonia Skarlatos and Catherine McKeon have played vital roles in catalyzing the difficult but eventually successful evolution of gene therapy from interesting new science with great potential to a remarkably successful field of clinical medicine. They have become the two most essential intermediaries in the scientific and translation conversation between the ASGCT and the NIH. With one foot at the NIH and another in the ASGCT, Drs. Skarlatos and McKeon have coalesced the programs in the two institutions and have worked enthusiastically and tirelessly to bring the dream of gene therapy to reality,” said Dr. Theodore M. Friedmann, past President of ASGCT and professor at the University of San Diego School of Medicine.

The American Society of Gene & Cell Therapy (ASGCT) is a professional nonprofit medical and scientific organization dedicated to the understanding, development and application of genetic and cellular therapies and the promotion of professional and public education in the field. For more information on ASGCT, visit its website, http://www.asgct.org.

###

Read the full story at http://www.prweb.com/releases/2013/5/prweb10723728.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Pioneering electrical engineering work recognized
2. Biscayne Pharmaceuticals Closes $1.5 Million Financing To Advance Recent Discoveries Of Pioneering Endocrine Drug Researcher
3. Oxitec Recognised by Prestigious Frost and Sullivan Award for its Pioneering System of Pest Control
4. Reproductive Medicine Associates of New Jersey Receives ACOG Prize for Paper on SET and CCS, a Pioneering IVF Process
5. New England Biolabs Introduces Polbase, an Information Repository of Scientific Data for Polymerase Researchers
6. In new quantum-dot LED design, researchers turn troublesome molecules to their advantage
7. Multidisciplinary team of researchers develop world’s lightest material
8. Researchers shrink tumors and minimize side effects using tumor-homing peptide to deliver treatment
9. Innovative MetaMorph® NX Software Shatters Barriers Between Researchers and Image Analysis Goals with Exclusive Visual Workflow
10. UCLA researchers demonstrate fully printed carbon nanotube transistor circuits for displays
11. Penn and Brown researchers demonstrate earthquake friction effect at the nanoscale
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... Curoverse announced ... On Azure, Arvados provides capabilities for managing and processing genomic and health data ... from major institutions collecting and analyzing genomic data,” said Adam Berrey chief executive ...
(Date:2/10/2016)... La Jolla CA (PRWEB) , ... February 10, 2016 , ... ... of new agents for the treatment of Alzheimer’s disease, announced today it has been ... to February 18th at the Breakers in Palm Beach, Florida. The purpose of ...
(Date:2/9/2016)... ... February 09, 2016 , ... With a presidential election ... Health Care Business Conference will bring together over 500 top healthcare leaders for a ... in transformation. The conference, organized by MBA students of the University of Pennsylvania’s Wharton ...
(Date:2/9/2016)... ... February 08, 2016 , ... Date ... S. Blumberg Institute at the Pennsylvania Biotechnology Center of Bucks County, 3805 Old ... Commonwealth Medical College (TCMC) will hold an open house for participants to learn ...
Breaking Biology Technology:
(Date:1/22/2016)... January 22, 2016 ... addition of the  "Global Behavioral Biometric ... --> http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has ... Behavioral Biometric Market 2016-2020"  report to ... and Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has announced ...
(Date:1/20/2016)... -- A market that just keeps on growing. Molecular ... in genomics knowledge. Learn all about it in this ... dynamic trends are pushing market growth and company valuations. ... - pathogen evolution - next generation sequencing - emergence ... of the role of genetic material in Disease and ...
(Date:1/18/2016)... Calif. , Jan. 18, 2016  Extenua ... software that simplifies the use and access of ... and go-to-market partnership with American Cyber.  ... brings extensive experience leading transformational C4ISR and Cyber ... and integrating the latest proven technology solutions," said ...
Breaking Biology News(10 mins):